BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34147474)

  • 1. Assessment of liver disease by non-invasive methods in perinatally infected Brazilian adolescents and young adults living with Human Immunodeficiency Virus (HIV).
    Gouvêa AFTB; Filho RC; Machado DM; Bononi do Carmo F; Beltrão SV; Sampaio L; de Moraes-Pinto MI; Succi RCM
    Braz J Infect Dis; 2021; 25(3):101589. PubMed ID: 34147474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults.
    Sterling RK; King WC; Wahed AS; Kleiner DE; Khalili M; Sulkowski M; Chung RT; Jain MK; Lisker-Melman M; Wong DK; Ghany MG;
    Hepatology; 2020 Feb; 71(2):411-421. PubMed ID: 31220357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C.
    Ragazzo TG; Paranagua-Vezozzo D; Lima FR; de Campos Mazo DF; Pessoa MG; Oliveira CP; Alves VAF; Carrilho FJ
    Clinics (Sao Paulo); 2017 Oct; 72(9):516-525. PubMed ID: 29069254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of liver fibrosis by transient elastography and multi-parameters model in young children with chronic hepatitis B virus infection.
    Luo H; Peng S; Ouyang W; Tan Y; Jiang T; Tang L; Li S; Qiu J; Zhou C
    BMC Infect Dis; 2022 Feb; 22(1):160. PubMed ID: 35180839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway.
    Sebastiani G; Milic J; Gioe C; Al Hinai AS; Cervo A; Lebouche B; Deschenes M; Cascio A; Mazzola G; Guaraldi G
    Lancet HIV; 2022 Mar; 9 Suppl 1():S4. PubMed ID: 35304846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.
    Amernia B; Moosavy SH; Banookh F; Zoghi G
    BMC Gastroenterol; 2021 Dec; 21(1):453. PubMed ID: 34861841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Roles of Fibrosis Index Based on Four Factors and Aspartate Transaminase-to-Platelet Ratio Index Scoring Systems as an Alternative to Transient Elastography Liver Stiffness in Liver Fibrosis Staging in Human Immunodeficiency Virus and Hepatitis C Virus Co-Infected Patients.
    Ajao S; Roach D; Chan KH; Thimmanagari K; Muhanna A; Mutyala M; Lakasanni S; Slim J
    Gastroenterology Res; 2021 Aug; 14(4):209-213. PubMed ID: 34527089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the diagnostic value of transient elastography, APRI and FIB-4 for liver fibrosis in children with non-alcoholic fatty liver disease].
    He SL; Li SJ; Liu M; Ouyang WX; Chen WJ; Zheng X; Jiang T; Tan YF; Kang Z; Qin XM; Yu Y
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):81-86. PubMed ID: 35152674
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.
    Li Vecchi V; Soresi M; Colomba C; Mazzola G; Colletti P; Mineo M; Di Carlo P; La Spada E; Vizzini G; Montalto G
    World J Gastroenterol; 2010 Nov; 16(41):5225-32. PubMed ID: 21049556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection.
    Zhu X; Wang LC; Chen EQ; Chen XB; Chen LY; Liu L; Lei XZ; Liu C; Tang H
    Dig Dis Sci; 2011 Sep; 56(9):2742-9. PubMed ID: 21399926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.
    Vinikoor MJ; Sinkala E; Mweemba A; Zanolini A; Mulenga L; Sikazwe I; Fried MW; Eron JJ; Wandeler G; Chi BH
    Liver Int; 2015 Jul; 35(7):1886-92. PubMed ID: 25581487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients.
    Kliemann DA; Wolff FH; Tovo CV; Alencastro PR; Ikeda ML; Brandão AB; Barcellos N; Fuchs SC
    Ann Hepatol; 2016; 15(1):27-32. PubMed ID: 26626637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs.
    Hasson H; Merli M; Galli L; Gallotta G; Carbone A; Messina E; Bagaglio S; Morsica G; Salpietro S; Castagna A; Lazzarin A; Uberti-Foppa C
    Liver Int; 2013 Aug; 33(7):1113-20. PubMed ID: 23534616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients.
    Yunihastuti E; Wicaksana B; Wiraguna A; Hidayah AJ; Amelia F; Natali V; Widhani A; Sulaiman AS; Kurniawan J
    BMC Infect Dis; 2020 May; 20(1):372. PubMed ID: 32450844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastography and serum markers of fibrosis versus liver biopsy in 1270 Egyptian patients with hepatitis C.
    Abdelsameea E; Alsebaey A; Abdel-Razek W; Ehsan N; Morad W; Salama M; Waked I
    Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1553-1558. PubMed ID: 31972660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection.
    Yosry A; Fouad R; Alem SA; Elsharkawy A; El-Sayed M; Asem N; Hassan E; Ismail A; Esmat G
    Arab J Gastroenterol; 2016 Jun; 17(2):78-83. PubMed ID: 27353055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.
    Mazzola G; Adamoli L; Calvaruso V; Macaluso FS; Colletti P; Mazzola S; Cervo A; Trizzino M; Di Lorenzo F; Iaria C; Prestileo T; Orlando A; Di Marco V; Cascio A
    Infection; 2019 Jun; 47(3):409-415. PubMed ID: 30519966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients.
    Abdel-Hameed EA; Rouster SD; Kottilil S; Sherman KE
    Clin Infect Dis; 2021 Aug; 73(3):450-459. PubMed ID: 32459305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of biliary atresia using liver transient elastography.
    Yeung F; Fung ACH; Chung PHY; Chu YY; Seto WK; Wong KKY
    Pediatr Surg Int; 2022 Jul; 38(7):1013-1018. PubMed ID: 35523886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
    Valcour VG; Rubin LH; Obasi MU; Maki PM; Peters MG; Levin S; Crystal HA; Young MA; Mack WJ; Cohen MH; Pierce CB; Adimora AA; Tien PC;
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):266-73. PubMed ID: 26885801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.